Impact of COVID-19 pandemic on pharmacologic treatment of patients newly diagnosed with osteoporosis

PURPOSE: This study determined whether initiation of pharmacologic treatment was delayed for newly diagnosed osteoporosis patients during the COVID-19 pandemic. METHODS: 1,189 patients ≥50 years with newly diagnosed osteoporosis using dual-energy x-ray absorptiometry (DXA) screening at a single acad...

Descripción completa

Detalles Bibliográficos
Autores principales: White, Micaela, Hisatomi, Lauren, Villegas, Alex, Pina, Dagoberto, Garfinkel, Alec, Agrawal, Garima, Punatar, Nisha, Wise, Barton L., Teng, Polly, Le, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499214/
https://www.ncbi.nlm.nih.gov/pubmed/37703271
http://dx.doi.org/10.1371/journal.pone.0291472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499214/
https://www.ncbi.nlm.nih.gov/pubmed/37703271
http://dx.doi.org/10.1371/journal.pone.0291472

Ejemplares similares